NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO)

Historical Holders from Q1 2014 to Q4 2024

Symbol
NWBO on OTC
CUSIP
66737P600
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
712K
Holdings value
$196K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
9
Number of buys
2
Number of sells
-3
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 712K $196K -$3.82K $0.27 9
2024 Q3 655K $209K -$10.2K $0.32 9
2024 Q2 670K $286K +$26.8K $0.43 11
2024 Q1 587K $304K +$45.3K $0.52 8
2023 Q4 521K $365K -$9.14K $0.70 8
2023 Q3 530K $482K +$20.9K $0.91 9
2023 Q2 2.98M $1.69M -$168K $0.57 10
2023 Q1 3.21M $2.01M +$255K $0.63 13
2022 Q4 2.82M $2.25M +$538K $0.78 14
2022 Q3 953K $680K -$31.7K $0.71 11
2022 Q2 1M $633K +$85.4K $0.63 13
2022 Q1 868K $603K +$29.7K $0.70 14
2021 Q4 824K $576K +$327K $0.70 12
2021 Q3 354K $453K -$58.9K $1.28 10
2021 Q2 394K $577K +$113K $1.46 13
2021 Q1 316K $472K +$70.2K $1.49 10
2020 Q4 269K $409K +$183K $1.51 8
2020 Q3 149K $114K +$26.4K $0.76 5
2020 Q2 112K $38K -$17.7K $0.34 4
2020 Q1 215K $34K +$21K $0.16 5
2019 Q4 92.5K $20K $0 $0.21 4
2019 Q3 92.5K $22K -$29K $0.24 4
2019 Q2 143K $37K +$2.4K $0.26 4
2019 Q1 134K $36K -$5.98K $0.26 4
2018 Q4 167K $34K +$9K $0.20 6
2018 Q3 123K $23K +$2K $0.19 4
2018 Q2 113K $29K $0 $0.26 4
2018 Q1 113K $29K +$15.7K $0.26 4
2017 Q4 52.5K $13K $0 $0.25 3
2017 Q3 52.5K $10K +$6K $0.20 3
2017 Q2 24.7K $4K $0 $0.16 2
2017 Q1 12.2K $2K -$8.8M $0.16 1
2016 Q4 25.4M $8.83M -$4.14M $0.35 7
2016 Q3 33.4M $18.1M -$1.75M $0.54 41
2016 Q2 36.7M $21.3M -$4.19M $0.58 53
2016 Q1 42M $61.3M +$4.15M $1.46 65
2015 Q4 38.8M $124M +$15.7M $3.20 72
2015 Q3 33.7M $210M +$24.9M $6.25 74
2015 Q2 28.8M $286M +$117M $9.93 78
2015 Q1 17.5M $129M +$22.4M $7.37 71
2014 Q4 14.6M $78.1M -$3.77M $5.35 65
2014 Q3 8.64M $43.5M +$531K $5.03 66
2014 Q2 8.4M $56.3M +$7.48M $6.71 76
2014 Q1 7.19M $52.1M +$8.76M $7.24 55